PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
78.42
-0.17 (-0.22%)
Jul 20, 2026, 10:19 AM EDT - Market open
PTC Therapeutics Employees
PTC Therapeutics had 991 employees as of December 31, 2025. The number of employees increased by 52 or 5.54% compared to the previous year.
Employees
991
Change (1Y)
52
Growth (1Y)
5.54%
Revenue / Employee
$834,622
Profits / Employee
-$188,423
Market Cap
6.50B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 991 | 52 | 5.54% | 991 | 0 |
| Dec 31, 2024 | 939 | -116 | -11.00% | 939 | 0 |
| Dec 31, 2023 | 1,055 | -355 | -25.18% | 988 | 67 |
| Dec 31, 2022 | 1,410 | 233 | 19.80% | 1,402 | 8 |
| Dec 31, 2021 | 1,177 | 210 | 21.72% | 1,167 | 10 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Mirum Pharmaceuticals | 418 |
| Rhythm Pharmaceuticals | 414 |
| Xenon Pharmaceuticals | 370 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
| Definium Therapeutics | 106 |
| Erasca | 103 |
PTCT News
- 3 hours ago - PTC Therapeutics price target lowered to $93 from $95 at Wells Fargo - TheFly
- 4 days ago - PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026 - PRNewsWire
- 4 days ago - PTC Therapeutics price target raised to $130 from $124 at Cantor Fitzgerald - TheFly
- 5 days ago - PTC Therapeutics price target raised to $95 from $93 at BofA - TheFly
- 7 days ago - PTC Therapeutics price target raised to $91 from $89 at JPMorgan - TheFly
- 13 days ago - PTC Therapeutics price target raised to $85 from $82 at RBC Capital - TheFly
- 4 weeks ago - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 4 weeks ago - PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes - PRNewsWire